Table 1.
Correlation between circEYA3 and clinicopathological parameters in PDAC form TMA (n = 209)
Characteristic | Total (209) | circEYA3 expression | P value | |
---|---|---|---|---|
Low (71) | High (138) | |||
Age | ||||
≤ 60 | 94 | 30 | 64 | |
> 60 | 115 | 41 | 74 | 0.570 |
Sex | ||||
Male | 105 | 30 | 75 | |
Female | 104 | 41 | 63 | 0.098 |
Tumor location | ||||
Head | 64 | 21 | 43 | |
Body/tail | 145 | 50 | 95 | 0.814 |
Grade | ||||
High/Moderate | 142 | 52 | 90 | |
Low | 67 | 19 | 48 | 0.239 |
TNM stage | ||||
I | 51 | 32 | 19 | |
IIA | 30 | 14 | 16 | |
IIB | 83 | 22 | 61 | |
III + VI | 45 | 3 | 42 | 0.000*** |
CA19–9 level | ||||
≤ 37 U/mL | 44 | 25 | 19 | |
> 37 U/mL | 165 | 46 | 119 | 0.000*** |
***P < 0.001